Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Steris (STE) and Roche Holding AG (OtherRHHVF)

Tipranks - Thu Feb 5, 5:54PM CST

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Steris (STEResearch Report) and Roche Holding AG (RHHVFResearch Report).

Claim 50% Off TipRanks Premium

Steris (STE)

In a report released today, Michael Matson from Needham maintained a Hold rating on Steris. The company’s shares closed last Wednesday at $264.27.

According to TipRanks.com, Matson is a 3-star analyst with an average return of 1.0% and a 43.3% success rate. Matson covers the Healthcare sector, focusing on stocks such as Insight Molecular Diagnostics, Establishment Labs Holdings, and Zimmer Biomet Holdings. ;'>

Currently, the analyst consensus on Steris is a Moderate Buy with an average price target of $295.50.

See Insiders’ Hot Stocks on TipRanks >>

Roche Holding AG (RHHVF)

In a report released today, Sarita Kapila from Morgan Stanley maintained a Sell rating on Roche Holding AG, with a price target of CHF295.00. The company’s shares closed last Wednesday at $458.53.

According to TipRanks.com, Kapila is ranked #9785 out of 12040 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Roche Holding AG with a $446.26 average price target, representing a -2.3% downside. In a report issued on January 27, Jefferies also maintained a Sell rating on the stock with a CHF230.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.